A first-moving cannabis API (Active Pharmaceutical Ingredient) manufacturer in Italy, operating in an EU-GMP-certified facility, is positioned to lead the country's developing medical cannabis market. Backed by an expert team, advanced production capabilities, with a focus on cannabinoid extraction and formulation, this company is prepared to meet Italy's growing demand for medicinal cannabis products.
Business Highlights:
- First-Mover Advantage: Leading the introduction of standardized cannabinoid APIs based on phyto-complex formulations to the Italian market.
- Strategic Growth Path: Operational and in the pre-revenue stage, the company is following a step-by-step licensing process and has achieved its first milestone as an API distributor.
- Advanced Facility:
- 200 sq. m. pharmaceutical production facility with cleanrooms, a finishing lab, and internal quality control labs.
- Equipped with state-of-the-art monitoring systems for pressure, temperature, and humidity to ensure strict compliance with pharmaceutical standards.
- Expert Team: A team of highly skilled professionals with strong regulatory knowledge and a reliable scientific network, will ensure operations will run smoothly and in full compliance.
- Market Demand: Positioned to meet Italy's growing demand for medical cannabis, a market underserved by companies specializing in regulatory-compliant APIs tailored for clinical trials and therapeutic needs.
- Business Potential: This is a promising chance to launch medical cannabis flowers and oil products in Italy's highly regulated cannabis market.
Investment Opportunity:
- Seeking an equity investment of up to €1.5 million to expand its production facility and develop a diverse portfolio of high-quality medicinal cannabis products.
- Potential to introduce cannabis flowers and oils, unlocking new revenue streams in Italy’s complex and regulated cannabis market.
This is a unique opportunity to partner with a first-mover in the Italian medical cannabis market, offering innovative API manufacturing, advanced facilities, and has a significant potential for growth.
